PTX 2.13% 4.6¢ prescient therapeutics limited

Omicar - Business Development, page-35

  1. 31 Posts.
    lightbulb Created with Sketch. 8
    Great results at ASCO for a biotech developing CAR-T therapy based on similar tech to OmniCAR by my reading ...
    https://www.arcellx.com/technology/

    Arcellx just released fantastic trial results for their multiple myeloma CAR-t based on this tech and the share price rocketed to >$us16
    https://www.fiercebiotech.com/biotech/asco-any-way-you-slice-it-arcellxs-car-t-matching-jj-legends-carvykti-analyst-says

    PTX just need to get OmniCAR preclinical data finished, excite biotech in the CAR T world based on the scalability and "dosability" of their platform for clinical manufacture and patient delivery of CAR T, choose the right target for the right cancer of unmet need and "BAM, POW" (Batman style)..UP will GO the SP !
    (IMHO of course)
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.6¢
Change
-0.001(2.13%)
Mkt cap ! $37.04M
Open High Low Value Volume
4.7¢ 4.9¢ 4.6¢ $46.00K 956.7K

Buyers (Bids)

No. Vol. Price($)
3 86350 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 155539 3
View Market Depth
Last trade - 16.10pm 10/06/2024 (20 minute delay) ?
Last
4.8¢
  Change
-0.001 ( 4.35 %)
Open High Low Volume
4.7¢ 5.0¢ 4.7¢ 566571
Last updated 13.35pm 10/06/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.